Bangladesh’s Beximco, Eskayef introduce generic versions of Pfizer's COVID pill
Bangladeshi pharmaceutical companies Beximco and Eskayef have been given the green light to launch generic versions of US drugmaker Pfizer’s highly promising oral treatment for COVID-19. Beximco Pharmaceuticals Limited said in a London Stock Exchange filing on Thursday that it...